Your browser doesn't support javascript.
loading
BNT162b2 Vaccine Encoding the SARS-CoV-2 P2 S Protects Transgenic hACE2 Mice against COVID-19.
Ji, Rui-Ru; Qu, Yajin; Zhu, Hua; Yang, Yumei; Vogel, Annette B; Sahin, Ugur; Qin, Chuan; Hui, Aimin.
Afiliación
  • Ji RR; Shanghai Fosun Pharmaceutical Industrial Development, Co. Ltd., 1289 Yishan Road, Shanghai 200233, China.
  • Qu Y; NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021,
  • Zhu H; NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021,
  • Yang Y; Shanghai Fosun Pharmaceutical Industrial Development, Co. Ltd., 1289 Yishan Road, Shanghai 200233, China.
  • Vogel AB; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Sahin U; BioNTech, An der Goldgrube 12, 55131 Mainz, Germany.
  • Qin C; TRON gGmbH-Translational Oncology at the University Medical Centre of the Johannes Gutenberg University, Freiligrathstraße 12, 55131 Mainz, Germany.
  • Hui A; NHC Key Laboratory of Human Disease Comparative Medicine, Beijing Key Laboratory for Animal Models of Emerging and Remerging Infectious Diseases, Institute of Laboratory Animal Science, Chinese Academy of Medical Sciences and Comparative Medicine Center, Peking Union Medical College, Beijing 100021,
Vaccines (Basel) ; 9(4)2021 Apr 01.
Article en En | MEDLINE | ID: mdl-33915773
ABSTRACT
BNT162b2 is a highly efficacious mRNA vaccine approved to prevent COVID-19. This brief report describes the immunogenicity and anti-viral protective effect of BNT162b2 in hACE2 transgenic mice. Prime-boost immunization with BNT162b2 elicited high titers in neutralizing antibodies against SARS-CoV-2, which correlated with viral clearance and alleviated lung lesions in these mice after viral challenge.
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2021 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Vaccines (Basel) Año: 2021 Tipo del documento: Article País de afiliación: China